The BMC’s health department has announced it will administer the BCG vaccine to adults as part of a proactive measure to curb tuberculosis (TB). This decision comes amidst a trial study aimed at evaluating the efficacy of the vaccine in TB prevention. The civic body has identified six high-risk groups, aged 18 and above, in the city to take part in this trial. However, since it is a voluntary vaccination, written consent will need to be obtained from eligible beneficiaries before administering the vaccine. The trial will begin in May. Every year March 24 is observed worldwide as World TB Day, advocating for concerted global action to combat this infectious disease. Aligning with this year’s theme, “Yes, We Can End TB,” the BMC has embarked on a trial initiative deploying the BCG vaccine. The initiative is bolstered by collaborative efforts from the Indian Council of Medical Research (ICMR) and National Tuberculosis Elimination Program (NTEP), who have initiated the vaccination programme. “The vaccine trials will be implemented systematically, with health volunteers and ASHA workers conducting surveys …